Patent application number | Description | Published |
20080311267 | Direct dissolution - The present disclosure describes a method for the continuous dissolution of e.g. crystalline astaxanthin or canthaxanthin suspension in oil, by applying heat for a predetermined period using an in-line or optionally batch wise-process, followed by cooling the heated solution with an oil phase or heat exchanger. The resulting oil solution may be used as such or added directly to feed components which are turned into feed compositions by extrusion, compaction or granulation. Alternatively the oil solution is spray coated or directly loaded to extruded or compacted pellets and granulates. The disclosure avoids using formulated carotenoids prepared by known multi-step production methods requiring solvents, solvent removal, cooling and emulsification with an aqueous phase or precipitation and recovery steps. Thus the present invention is a more economical, efficient and environmentally friendly method to add nutrients and colourants to feed compositions instead of using colloid dispersed particulate hydrocolloid compositions. | 12-18-2008 |
20130055831 | DISSOLUTION COMPOSITION FOR EXAMINING DRUG SOLUBILITY - There are described solid compositions or examining drug solubility comprising bile salts and phospholipids, optionally containing buffer components suitable for preparation of intestinal media that simulate the composition of the intestinal fluids in fasted and fed states. | 03-07-2013 |
20150064794 | BIORELEVANT COMPOSITIONS - This application relates to a homogeneous biorelevant composition for preparing fasted state biorelevant media having a surface tension between 25 mN/m and 50 mN/m for simulating fasted state gastric and fasted state upper small intestinal fluids of mammalian species, especially humans, dogs, etc. comprising at least one bile salt, eg. sodium taurocholate or sodium taurodeoxycholate; at least one phospholipid, especially 60-99 wt % phosphatidylcholine (PC), enzyme digested diacylphospholipids containing 50-90 wt % of monoacyl-PC; or mixtures thereof; and at least one fatty acid or monovalent salt of the fatty acid, such as sodium oleate. The application also relates to an aqueous biorelevant media composed of surfactants occurring in the gastrointestinal tract of mammals, in particular when prepared from above homogeneous biorelevant composition. | 03-05-2015 |
Patent application number | Description | Published |
20080231343 | Method and System for Vibration Sensing Power Management - The invention provides in one aspect a method for vibration sensing. The method comprises powering down at least one electronic component required for recording vibration data; powering down a processor used to carry out one or more steps of the method; measuring the vibration level of a machine in a frequency band of interest; comparing the measured vibration level with a user-selected reference vibration level; and powering up the processor if the measured vibration level is greater than or equal to the reference vibration level. In another aspect the invention provides a system for vibration sensing. | 09-25-2008 |
20080234983 | Method and system for vibration signal processing - The present invention relates to a vibration signal processing method and system that can be used to account for situations where impact or impulse events are hidden in a normal vibration reading by low frequency vibrations and high frequency noise. In one preferred form, the method of the present invention comprises the steps of obtaining electrical vibration signals that represent mechanical vibrations of a machine ( | 09-25-2008 |
20110015899 | Vibration Analysis - The present invention relates to vibration analysis and in particular, but not limited to, the derivation of multiple types of vibration signals from one vibration signal for vibration analysis. In the preferred method of the invention the vibrations of an object are measured using at least one vibration sensor, wherein the vibration sensor converts vibrations into an electrical vibration signal. The electrical vibration signal is digitized based on a first frequency, wherein the first frequency is selected from a plurality of possible frequency values. A first type of vibration signal is derived from the digitized vibration signal. A second type of vibration signal is then derived from the digitized vibration signal based on a second frequency. The second frequency is rationally determined from, and lower than, the value selected for the first frequency. The invention also provides apparatus for deriving multiple types of vibration signals from one measured vibration signal for vibration analysis. | 01-20-2011 |
Patent application number | Description | Published |
20140022157 | METHOD AND DISPLAY APPARATUS FOR PROVIDING CONTENT - A method and display apparatus for providing content are provided. The method for providing content includes displaying a content UI in which a plurality of content is included, detecting an area at which a user gazes in the content UI, determining a preference for gaze content that is present in the area at which the user gazes by measuring user's brainwaves, and providing the content UI based on the determined preference. The user can be provided with the content UI that is configured more intuitively and conveniently according to the user preference. | 01-23-2014 |
20140022159 | DISPLAY APPARATUS CONTROL SYSTEM AND METHOD AND APPARATUS FOR CONTROLLING A PLURALITY OF DISPLAYS - A display apparatus control system and a method and apparatus for controlling a plurality of display apparatuses are provided. The method of controlling a plurality of display apparatuses includes capturing a region at which a user is located, generating a user-captured image, determining which display apparatus the user is looking at from among the plurality of display apparatuses, based on the user-captured image, and determining the determined display apparatus to be a control target display apparatus, and transmitting a control signal which corresponds to a user's command to be the control target display apparatus when the user's command is input. | 01-23-2014 |
20140022351 | PHOTOGRAPHING APPARATUS, PHOTOGRAPHING CONTROL METHOD, AND EYEBALL RECOGNITION APPARATUS - A photographing control method is provided. The photographing control method includes capturing an image of an object, detecting a facial area from within the captured image of the object, adjusting a location of the photographing apparatus based on a location of the detected facial area, and adjusting a zooming state of the photographing apparatus so that a size of the detected facial area falls within a predetermined size range. | 01-23-2014 |
20150015483 | METHOD OF CONTROLLING AT LEAST ONE FUNCTION OF DEVICE BY USING EYE ACTION AND DEVICE FOR PERFORMING THE METHOD - A method of controlling a device by an eye action is provided. The method includes selecting a controller to execute a control command generated by the eye action of a user, obtaining data about the eye action of the user, detecting the control command corresponding to the eye action of the user based on the obtained data, and executing the detected control command by using the selected controller. | 01-15-2015 |
20150091793 | METHOD FOR CONTROLLING DEVICE ON THE BASIS OF EYEBALL MOTION, AND DEVICE THEREFOR - A method of controlling an operation of a display device using eye movements and a device for performing the method are provided. The method includes receiving eye movement information of a user; receiving blinking information of the user; generating a control command corresponding to the eye movement information and the blinking information; and controlling an operation of the display device based on the generated control command. | 04-02-2015 |
Patent application number | Description | Published |
20080234521 | CRYSTAL FORMS OF ASTAXANTHIN - Mixtures of specific crystal forms of astaxanthin and the individual crystal forms designated crystal Form I and II and disclosed together with methods for preparing said crystal Forms. Methods for preparing nutritional dosage forms including the disclosed astaxanthin crystal forms for the life science industry are also disclosed. | 09-25-2008 |
20080311267 | Direct dissolution - The present disclosure describes a method for the continuous dissolution of e.g. crystalline astaxanthin or canthaxanthin suspension in oil, by applying heat for a predetermined period using an in-line or optionally batch wise-process, followed by cooling the heated solution with an oil phase or heat exchanger. The resulting oil solution may be used as such or added directly to feed components which are turned into feed compositions by extrusion, compaction or granulation. Alternatively the oil solution is spray coated or directly loaded to extruded or compacted pellets and granulates. The disclosure avoids using formulated carotenoids prepared by known multi-step production methods requiring solvents, solvent removal, cooling and emulsification with an aqueous phase or precipitation and recovery steps. Thus the present invention is a more economical, efficient and environmentally friendly method to add nutrients and colourants to feed compositions instead of using colloid dispersed particulate hydrocolloid compositions. | 12-18-2008 |
20090145248 | DISSOLUTION COMPOSITION FOR EXAMINING DRUG SOLUBILITY - There are described solid compositions or examining drug solubility comprising bile salts and phospholipids, optionally containing buffer components suitable for preparation of intestinal media that simulate the composition of the intestinal fluids in fasted and fed states. | 06-11-2009 |
20110244028 | METHOD OF SOLUBILIZING BIOLOGICALLY ACTIVE COMPOUNDS - The invention describes a method of preparing lipid compositions by associating pH sensitive compounds which maybe weak acids, bases or amphoteric compounds with at least one ionisable or pH sensitive group and low water solubility into preformed and standardised lipid particles by pH manipulation. Drug association is carried out in situ by changing the pH of the aqueous medium to pH 6-8 wherein the compound spontaneously partitions into the lipid particles. Drug association may also be carried out by exploiting pH changes in the GI tract. The lipophilic compound is solubilised by the lipid particles and may be used as such for in-vitro and pharmacokinetic assessments or processed for oral, parenteral or topical therapy. | 10-06-2011 |
20130055831 | DISSOLUTION COMPOSITION FOR EXAMINING DRUG SOLUBILITY - There are described solid compositions or examining drug solubility comprising bile salts and phospholipids, optionally containing buffer components suitable for preparation of intestinal media that simulate the composition of the intestinal fluids in fasted and fed states. | 03-07-2013 |
20150064794 | BIORELEVANT COMPOSITIONS - This application relates to a homogeneous biorelevant composition for preparing fasted state biorelevant media having a surface tension between 25 mN/m and 50 mN/m for simulating fasted state gastric and fasted state upper small intestinal fluids of mammalian species, especially humans, dogs, etc. comprising at least one bile salt, eg. sodium taurocholate or sodium taurodeoxycholate; at least one phospholipid, especially 60-99 wt % phosphatidylcholine (PC), enzyme digested diacylphospholipids containing 50-90 wt % of monoacyl-PC; or mixtures thereof; and at least one fatty acid or monovalent salt of the fatty acid, such as sodium oleate. The application also relates to an aqueous biorelevant media composed of surfactants occurring in the gastrointestinal tract of mammals, in particular when prepared from above homogeneous biorelevant composition. | 03-05-2015 |